life expectancyAcute myeloid leukemia (AML) can be diagnosed at any age and treatment, which can be given with supportive and/or curative intent, is considered expensive compared with that for other cancers. Despite this, no long-term predictive models have been developed for AML, mainly because...
8 Treatment of the elderly patient with acute myeloid leukaemia SummaryIndividuals of 60 years living in western countries generally have a mean life expectancy of 20 years at least. Therefore, when aged individuals pre... B Löwenberg - 《Baillières Clinical Haematology》 被引量: 489发表: 199...
Acute myeloid leukemia (AML) presents in all ages but is mainly a disease of the elderly with a median age of 69 years in the white US population of the Surveillance, Epidemiology, and End Results database.1 Age has a major impact on the management and outcome for patients with AML. El...
Is it time to redefine response in elderly patients with WHO-acute myeloid leukemia (AML) unfit for intensive chemotherapy? Blood. 2015;126:abstract 3742. Google Scholar Schuh A, Dombret H, Sandhu I, Seymour JF, Stone RM, Al-Ali HK, Alimena G, Lewis I, Sang Kyun S, Geddes M, ...
Although treatment of childhood acute myelogenous leukemia (AML) has substantially improved in the last 15 years, in nearly half of the patients disease recurs. The aim of this study was to establish the prognosis of relapsed childhood AML and to identif
Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemia. Med Oncol 2012; 29: 1077–1081. Article Google Scholar Morra E, Barosi G, Bosi A, Ferrara F, Locatelli F, Marchetti M et al. Clinical ...
Viruses are obligate intracellular pathogens that cause infection in susceptible host cells. Virus infections could be lytic, chronic, latent or immortalizing. Viruses causing latent infection are associated with high morbidity and mortality worldwide. The human body is protected from viral infection by...
Acute myeloid leukemiaElderlyAdverse prognostic factorOverall survivalPopulation-based studyAIM: To elucidate risk factors for survival of elderly acute myeloid leukemia(AML) patients in a real-world practice by observational study. METHODS: We conducted a population-based study in 213 adult and elderly...
Although treatment of childhood acute myelogenous leukemia (AML) has substantially improved in the last 15 years, in nearly half of the patients disease recurs. The aim of this study was to establish the prognosis of relapsed childhood AML and to identif
Overall, the median life expectancy is rising world-wide, being in the western world around/over 80years (and increasing); in addition, the proportion of elderly individuals is growing progressively. This means that the management of these frail patients represents a true clinical unmet need. ...